NCT02923284View on ClinicalTrials.gov

NANOTECH RCC Biomarkers

CompletedOBSERVATIONAL
Enrollment

407

Participants

Timeline

Start Date

August 31, 2016

Primary Completion Date

January 2, 2020

Study Completion Date

January 2, 2020

Conditions
Renal Cell CarcinomaRenal Cell Cancer
Trial Locations (1)

63110

Washington University St Louis School of Medicine, St Louis

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Washington University School of Medicine

OTHER

NCT02923284 - NANOTECH RCC Biomarkers | Biotech Hunter | Biotech Hunter